Table 3: The posterior inclusion probability and description of the leading 20 genes for the leukemia study. Genes identified in other studies were also noted.

GeneProbabilityDescription

X957350.0691Zyxinabc
M278910.0519CST3 cystatin C (amyloid angiopathy and cerebral hemorrhage)abc
M231970.0302CD33 cD33 antigen (differentiation antigen)abc
Y126700.0251LEPR leptin receptora
X851160.0226Epb72 gene exon 1ab
D884220.0196CYSTATIN Abc
X626540.0196ME491 gene extracted from H.  sapiens gene for Me491/CD63 antigenb
X040850.0195Catalase (EC 1.11.1.6) 5′ank and exon 1 mapping to chromosome 11, band p13 (and joined CDS)a
L092090.0195APLP2 amyloid beta (A4) precursor-like protein 2bc
HG1612-HT16120.0186Macmarcksbc
M160380.0186LYN V-yes-1 Yamaguchi sarcoma viral related oncogene homologabc
U501360.0181Leukotriene C4 synthase (LTC4S) geneab
M551500.0172FAH fumarylacetoacetateab
M922870.0172CCND3 cyclin D3bc
M229600.0168PPGB protective protein for beta-galactosidase (galactosialidosis)bc
X702970.0168CHRNA7 cholinergic receptor, nicotinic, and alpha polypeptide 7b
X515210.0163VIL2 Villin 2 (ezrin)b
M631380.0154CTSD cathepsin D (lysosomal aspartyl protease)ab
M277830.0154ELA2 elastase 2, neutrophilc
U815540.0137CaM kinase II isoform mRNA

Gene also identified in Golub et al. [36].
bGene also identified in Ben-Dor et al. [38].
cGene also identified in in Lee et al. [22].